Orange Biomed

Orange Biomed was launched in 2021 by Duke University alumnus Dr. Unghyeon Ko and Yeaseul Park to solve unmet diabetes-focused healthcare needs.

The healthcare startup innovates cutting-edge technology for diabetes management, including OBM rapid A1c. Orange Biomed is currently conducting research studies for OBM rapid A1c at Seoul Asan Medical Center. Asan is South Korea's largest hospital and is backed by the Hyundai group, one of Korea's largest conglomerates with a strong emphasis on healthcare.

05/15/2026

🔊 We are thrilled to share that Orange Biomed has published another research paper in Lab on a Chip, one of the leading journals in the field of microfluidics : https://lnkd.in/gQWUpHxh

The paper, “Microfluidic Profiling of Suspension Cell Metal Adhesion at Single Cell Resolution Under Flow,” introduces a microfluidic platform integrated with metallic materials, enabling rapid, high-throughput quantification of non-specific cell adhesion at the single-cell level under flow conditions relevant to vascular applications and metallic implants.

This work represents a meaningful contribution not only to Orange Biomed’s HbA1c measurement platform, but also to broader applications involving blood-cell interactions with metallic materials across a range of medical devices and implant technologies.

For those interested in our technology and scientific work, we would love to connect and share more during our poster presentation at during the upcoming ADA 2026 Scientific Sessions this June. ✈️

05/04/2026

🍀For children and teenagers living with Type 1 diabetes, management is not just about knowing what to do.

It’s about learning how to do it—on their own.

And that’s not always easy.

Because growing up with diabetes means navigating more than numbers. It means balancing independence, responsibility, and sometimes, the quiet pressure of feeling like you’re the only one managing it.

But in some places, that experience changes.

At Camp Surefire, no one is the only one.

Everyone checks.
Everyone learns.
Everyone understands—without needing an explanation.

And that matters more than we often realize.

Because confidence doesn’t come only from instruction. It comes from seeing others like you— figuring it out, adjusting, and moving forward.

That’s how independence begins.

Not in isolation,
but in shared experience.

On May 3rd, Orange Biomed has brought M.A.P. Your Health to Rhode Island at Camp Surefire Open House, where we were grateful for the opportunity to connect with incredible children with T1D and their families. 🥰

Special thank you to Ali Fox for welcoming us and helping foster engagement across the Type 1 diabetes community.

We’re honored to support a mission dedicated to enriching the lives of children, families, and young adults living with T1D through year-round programming and connection.

04/27/2026

🏥Healthcare doesn’t only happen in hospitals.

It happens in everyday life, where people make decisions, build habits, and manage their conditions.

That’s why community-based programs matter.

At places like Camp Surefire , children living with Type 1 diabetes learn how to manage their condition in real-life environments, supported by peers, caregivers, and medical professionals.

On May 3rd, we’re excited to join the Camp Surefire Open House and be part of this community through a mini-experience. Read more about the partnership and upcoming event here : https://lnkd.in/eMuPea8j

MAP stands for Monitoring, Adapt, and Prevent,
a simple framework to help individuals better understand and manage their health over time.

Through this experience, we hope to engage with children and families, and support the importance of continuous awareness and everyday decision-making in diabetes care.

Special thank you to Ali Fox for welcoming us and helping foster engagement across the Type 1 diabetes community. We’re honored to support a mission dedicated to enriching the lives of children, families, and young adults living with T1D through year-round programming and connection.

Because better outcomes don’t come from isolated moments,
they come from what happens in between.

Sponsors of the Future

04/16/2026

Today is National Healthcare Decisions Day.

Clinical decisions are only as good as the data behind them.

In diabetes care,
the American Diabetes Association emphasizes
the importance of ongoing assessment—
not just point-in-time measurements.

Yet many decisions are still made
based on infrequent snapshots.

Health doesn’t happen in snapshots.
It happens over time.

Better decisions require better visibility—
not just more data, but better context.

03/05/2026

Happy

!

At Orange Biomed, we proudly lead efforts to advance women’s leadership and innovation in diabetes care. The 2026 International Women’s Day theme, “Give to Gain,” perfectly aligns with our commitment to empowering women who drive equitable health outcomes globally.

Our leadership team, including Yeaseul Park (CEO, Co-Founder), Eunyoung Park (Chief Research Officer, Co-Founder) You-ra Park, and 김고은 , exemplifies this mission through their dedication to diabetes innovation.

Meet our Leadership Team here: bit.ly/4hPZBMd

On March 6, 2026, at 12:30 PM CET, the International Diabetes Federation will host a webinar titled “Giving voice, gaining impact: women leading change in diabetes.” The event features inspiring speakers Konstantina Boumaki, Marlena Wilson, Isabella Magee, Kerry Murphy , and Osarenkhoe Chima-Nwogwugwu , who will share their experiences and advocacy efforts.

Learn more here: https://idf.org/events/webinars/giving-voice-gaining-impact/

01/15/2026

Day 3 at was incredibly insightful! 💡

The conference offered a valuable window into the strategic and financial thinking shaping the global diabetes landscape—across medical devices, pharmaceuticals, digital health, and medical supplies. Hearing perspectives from industry leaders such as Medtronic, Sanofi, Omada Health, and Embecta highlighted how leading companies are navigating a range of emerging opportunities—including, but not limited to, those being reshaped by GLP-1.

01/14/2026

DAY 2 at was incredibly fulfilling! ✨

Orange Biomed was honored to present as a finalist at the . We’re deeply grateful to the investors and attendees who showed strong interest and took the time to engage with us.

Thanks as well to , , , and for inviting us to valuabe private events. It was a pleasure reconnecting with familiar faces and meeting new ones—every conversation was both meaningful and energizing.

Special thanks to Taeyong Kim , CEO of EO Studio, for his invaluable entrepreneurial insights and for making a vibrant hub where founders connect, share, and grow their dreams. His perspective continues to inspire our journey. 🚀

Across key sessions, discussions consistently underscored diabetes and obesity as core aging-related diseases, emphasizing the importance of chronic monitoring alongside GLP-1 therapies for sustainable, long-term management.

This strongly reaffirmed that the direction Orange Biomed is pursuing is both timely and essential.

01/13/2026

What an incredible start to and !
Day 1 was buzzing with energy as we shared the power of OBM rapid A1c.🎉

Thank you to everyone who visited our booth 👋 — and to all those we connected with across the many JPM Week events in and around Union Square. We were truly honored by the insightful conversations and the keen interest shown in our mission.

Keeping the momentum going, Orange Biomed is thrilled to be a finalist presenter at the RESI Conference today.

Join our final pitch (Session 15):

Today, January 13th | 10:00 AM - 11:00 AM
Golden Gate C3 Room, Marriott Marquis San Francisco

See you there as we present our revolutionary technology!

01/12/2026

It's D-day! Orange Biomed is live at the in San Francisco! 🎉

Join us today to discover OBM rapid A1c, our innovative solution for precise and accessible diabetes monitoring. We can't wait to meet you! 👋

And the excitement continues! Orange Biomed is honored to be a finalist presenter at the Conference tomorrow.

01/09/2026

Happy New Year from the Orange Biomed team! As we reign in 2026, we’re pleased to look back on all of our milestones in 2025.

One milestone was the launch of our first nationwide campaign: (Monitor, Adapt, Prevent) created to empower communities to monitor their risk factors for chronic disease. M.A.P. Your Health aims close gaps in care and prevent long-term complications. The movement launched with a free webinar and an online portal providing educational resources to improve health literacy: https://map.orangebiomed.com/

The special edition webinar featured Orange Biomed CEO Yeaseul Park, in addition to U.S. leaders Pat Merryweather-Arges, Ny'Nika McFadden, PhD, John Robitscher, MPH, and Stacey Simms to raise awareness around disease prevention and global healthcare innovation.

We also hosted our first local event in the nationwide series: the M.A.P. Your Health Chicago Community Forum & Public Health Resource Fair. The event connected community members to valuable healthcare resources, including free testing, educational seminars led by healthcare professionals, activities with local community leaders, and more. Special thank you to Humboldt Park Health and our 20+ other community partners for joining the movement!

Our team also attended insightful conferences in 2025, where we showcased our innovative solution: OBM rapid A1c. The portable device utilizes microfluidic analysis technology to enable quick, lab-accurate testing We demonstrated OBM rapid A1c’s benefits for audiences at , , , , , , , and more.

Orange Biomed is grateful for the opportunities to amplify our message to various audiences through media features in blackdoctor.org, MLO - Medical Laboratory Observer, MD&DI, Fortune Korea, (KMGH-TV), health.tech, and more.

During , we spoke with Denver7 (KMGH-TV) to discuss disparities in diabetes care among Black populations and how we aim to improve diabetes management for all communities through more inclusive testing. Watch the full segment here: https://bit.ly/4ssMVk7

Our 2025 interview with Stacey Simms from is also now live! Listen to the podcast here: https://bit.ly/3YmueRx

Orange Biomed was also selected for BDMT Global and Fortune Korea’s 2025 Top 40 Innovations list, and was included in the Innovator Summit at MEDevice Boston, where we presented our breakthrough A1C testing solution and participated in the NEMIC (New England Medical Innovation Center) International Pitch Reception.

We received the Good Manufacturing Practice (GMP) certification for in vitro diagnostic medical devices from Korea's Ministry of Food and Drug Safety, granting us approval to scale production of OBM rapid A1c.

Thank you to our partners and sponsors for making 2025 a transformative year!

Orange Biomed’s next stop: . DM us to book a meeting!

Address

1065 Wordens Pond Rd
Wakefield, RI
02879

Website

https://www.orangebiomed.com/

Alerts

Be the first to know and let us send you an email when Orange Biomed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed Health & Beauty Business in Wakefield?